Probiotics' Role in Mitigating Intestinal Mucosal Damage and Dysbiosis in Infants with Congenital Heart Disease Undergoing Cardiopulmonary Bypass - Top-Institutions - MDSpire

Probiotics' Role in Mitigating Intestinal Mucosal Damage and Dysbiosis in Infants with Congenital Heart Disease Undergoing Cardiopulmonary Bypass

By
Zhixuan Zhang
Xiaoxu Liu
Zhaocong Yang
Lan Jiang
Chengbin Tang
Xuming Mo
April 24, 2026
0 min

Frontiers In Immunology

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

#1

Boston Children's Hospital

Boston, MA
Key Differentiators
- Pediatric Cardiology
- Pediatric Gastroenterology
- Microbiome Research
#2

Children's Hospital of Philadelphia (CHOP)

Philadelphia, PA
Key Differentiators
- Pediatric Cardiology
- Pediatric Gastroenterology
- Clinical Trials
#3

Cincinnati Children's Hospital Medical Center

Cincinnati, OH
Key Differentiators
- Pediatric Cardiology
- Pediatric Gastroenterology
- Microbiome and Immunology
#4

Stanford Children's Health / Lucile Packard Children's Hospital

Palo Alto, CA
Key Differentiators
- Pediatric Cardiology
- Pediatric Gastroenterology
- Microbiome Research

Original Source(s)

Frontiers In Immunology

Probiotics' Role in Mitigating Intestinal Mucosal Damage and Dysbiosis in Infants with Congenital Heart Disease Undergoing Cardiopulmonary Bypass

by Zhixuan Zhang, Xiaoxu Liu, Zhaocong Yang, Lan Jiang, Chengbin Tang, Xuming Mo
April 24, 2026

Related Content

Frontiers In Medicine

The Connection Between Periodontal Microbiota and Liver Disease Development: Insights into the Oral-Gut-Liver Axis

by Fagui Wu, Yuxin Chen, Xiuqin Ni, Tingzhuang Yi, Shengkui Tan
April 23, 2026

Frontiers In Immunology

Innovative Fecal Microbiota Transplant Technique for Investigating Gut Microbiome's Influence on Stress Responses in Murine Models

Frontiers In Immunology

Multiniche mycobiome profiling identifies distinctive fungal dysbiosis in common variable immunodeficiency